Pharmaceuticals, Biotechnology and Life Sciences
CHLA Researchers receive CIRM award to develop regenerative therapy for recurring solid tumors in children. LOS ANGELES–(BUSINESS WIRE)–Children’s Hospital Los…
Cemiplimab is an effective PD-1 inhibitor approved by the European Medicines Agency for certain patients with advanced basal cell carcinoma,…
Company unveils new innovative Oncology organization, strategic vision and approach, following the Seagen acquisition in late 2023 Robust portfolio and…
CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies,…
Major asset acquisition from a U.S.-based company marks another milestone for Canada’s largest biotechnology company VANCOUVER, British Columbia–(BUSINESS WIRE)–STEMCELL Technologies…
Core royalty platform on track; received GSK royalties of $69.6 million for fourth quarter Achieved net product revenues of $19.7…
LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the fourth quarter and year ended…
Determined maximum tolerated dose (MTD) in Phase 1 monotherapy study of NUV-868; Phase 1b studies of NUV-868 in combination with…
FY 2023 total revenues of $1.7M, a 420% increase over FY 2022 as EndeavorOTCⓇ gained traction in the market following…
NASHVILLE, Tenn.–(BUSINESS WIRE)–HealthTrust Performance GroupSM, a leading healthcare performance improvement company, will have a number of the organization’s executives and…